Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.71 -4.25 (-0.84%)
At close: Oct 1, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) reported Depreciation & Amortization (CF) of $381,000 for Q2 2026, up 1.1% from $377,000 a year earlier but down 1.3% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Madrigal Pharmaceuticals' Depreciation & Amortization (CF) came in at $1.52 million, up 7.1% year-over-year; for FY2025, it came in at $1.51 million, up 37.4% from FY2024.

  • Depreciation & Amortization (CF) has increased for four consecutive years, with a five-year compound annual growth rate of 26.2% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $1.1 million in FY2024 (+108.0%), $527,000 in FY2023 (+12.8%), $467,000 in FY2022 (+15.3%) and $405,000 in FY2021 (-14.0%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $97,000 in Q3 2021 and a high of $392,000 in Q4 2025.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last 17 quarters, with growth averaging 59.3% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2024 (growth of 155.6%); the low point was Q3 2021 (a decline of 15.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $386,000 (Q1 2026), $392,000 (Q4 2025) and $358,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Madrigal Pharmaceuticals 14.69 Bn 10.94 Bn - 381,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 381,000.00
Mar 31, 2026 386,000.00
Dec 31, 2025 392,000.00
Sep 30, 2025 358,000.00
Jun 30, 2025 377,000.00
Mar 31, 2025 379,000.00
Dec 31, 2024 363,000.00
Sep 30, 2024 298,000.00
Jun 30, 2024 267,000.00
Mar 31, 2024 168,000.00
Dec 31, 2023 142,000.00
Sep 30, 2023 135,000.00
Jun 30, 2023 126,000.00
Mar 31, 2023 124,000.00
Dec 31, 2022 129,000.00
Sep 30, 2022 121,000.00
Jun 30, 2022 110,000.00
Mar 31, 2022 107,000.00
Dec 31, 2021 106,000.00
Sep 30, 2021 97,000.00
API Access

Madrigal Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MDGL&period=max&api_key=YOUR_API_KEY